TRIB Stock Analysis: Buy, Sell, or Hold?
TRIB - Trinity Biotech plc
$12.43
0.79 (6.79%)
▲
5d:
+7.16%
30d:
+3076.59%
90d:
+1999.66%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Get Alerted When TRIB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TRIB is 20.8% above its trading range ($10.29). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TRIB is 20.8% above its trading range ($10.29). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TRIB is currently trading at $12.43, which is considered extended relative to its 30-day fair value range of $-0.63 to $10.29.
Technical Outlook: Technically, TRIB is in a strong uptrend. Immediate support is located at $7.94, while resistance sits at $14.17. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: TRIB scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $3.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TRIB is in a strong uptrend. Immediate support is located at $7.94, while resistance sits at $14.17. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: TRIB scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $3.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.63 -
$10.29
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
10.5%
All Signals
- BEARISH: Price significantly overextended (+20.8% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BEARISH: Trading 75.9% above Wall St target ($3.00)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$-0.63 -
$10.29
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.94
Resistance Level
$14.17
Current Trend
Strong Uptrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.40
Wall Street Target
$3.00
(-75.9%)
Revenue Growth (YoY)
-5.5%
Earnings Growth (YoY)
-77.3%
Profit Margin
-85.4%
Share & Embed Analysis
Last updated: August 09, 2026 4:41 AM ET
Data refreshes hourly during market hours. Next update: 5:41 AM
Data refreshes hourly during market hours. Next update: 5:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRIB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 39 SELL |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 49 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 41 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 51 HOLD |